<DOC>
	<DOCNO>NCT00712413</DOCNO>
	<brief_summary>The purpose study evaluate effect Pylera give twice day . Pylera approve treatment schedule 3 pill take 4 time daily , addition omeprazole give twice daily . In trial , subject confirm Helicobacter Pylori infection receive Pylera treatment omeprazole twice daily .</brief_summary>
	<brief_title>Safety , Efficacy Pylera BID Dosing Eradication H. Pylori</brief_title>
	<detailed_description>This study include three phase : screening , treatment follow-up . Screening : phase last maximum 15 day subject eligibility evaluate informed consent signature . Urea breath test ( UBT ) perform addition routine baseline evaluation ( physical , lab test , etc ) . Treatment : subject treat 10 day . A `` confirmation eligibility '' visit take place Day 0 `` end-of-treatment '' visit take place day 9-14 . Follow-up : approximately one month post-treatment , eradication H. pylorus confirm UBT</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Positive H. pylorus status UBT test Documented allergy drug contain treatment regimen Severe renal insufficiency , renal failure azotemia Previous surgery upper gastrointestinal tract Hepatic failure Preexisting peripheral neuropathy Use experimental drug within 30 day prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Helicobacter pylorus infection</keyword>
	<keyword>Quadruple therapy</keyword>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Tolerability</keyword>
	<keyword>BID dose</keyword>
</DOC>